Drug donanemab seen as turning point in dementia fight
Drug donanemab seen as turning point in dementia fight
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
You're viewing a single thread.
It delays dementia by 4-7 months, and also causes bleeding and swelling in the brain which killed 3 out of 1,700 participants in the study.
It’s better than nothing I guess but it’s not a particularly good treatment.
Sure, but treatments of something that complex has to start somewhere. It seems to go in the right direction and upcoming treatments may build on that. I am not sure that anyone could have expected after many failures to just find the magical cure that completely cures Alzheimers.